Hemispherectomy for hemimegalencephaly in a 6.5-week-old infant with tuberous sclerosis complex

Childs Nerv Syst. 2022 Jul;38(7):1415-1419. doi: 10.1007/s00381-021-05431-1. Epub 2022 Jan 13.

Abstract

The aim of this report is to present a unique case of hemimegalencephaly and concomitant tuberous sclerosis complex (TSC1 mutation) with severe neonatal-onset epilepsy, which successfully underwent an anatomical hemispherectomy at 6.5 weeks of age for refractory seizures. Genetic testing confirmed a rare pathogenic, sporadic, heterozygous c.2041 + 1G > A gene mutation in intron 16 of the TSC1 gene, diagnostic for tuberous sclerosis. Post-operatively, the infant remained seizure free for at least 1 year. Following recurrence of her seizures, she has continued on multiple anti-seizure medications and everolimus therapy. We review the pathological and molecular features of this condition and highlight the ethics of intervention and steps taken toward safe neurosurgical intervention in this very young infant.

Keywords: Epilepsy; Hemispherectomy; Pediatrics; mTOR pathway.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Epilepsy* / surgery
  • Female
  • Hemimegalencephaly* / complications
  • Hemimegalencephaly* / diagnostic imaging
  • Hemimegalencephaly* / genetics
  • Hemispherectomy*
  • Humans
  • Infant
  • Infant, Newborn
  • Tuberous Sclerosis* / complications
  • Tuberous Sclerosis* / surgery